Advert - Takeda

For linking the company’s funding of a course in return for a health professional’s support for one of its medicines, Takeda was ruled in breach of the following clauses of the 2014 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Clause 9.1 - Failing to maintain high standards.

Clause 18.1 - Providing an inducement to prescribe to an individual.

Clause 18.6 - Providing an inducement to prescribe to an organisation comprised of health professionals.

The full case report was published in the PMCPA February 2017 Code of Practice Review and is available at www.pmcpa.org.uk.